Genprex, Inc. (GNPX)
NASDAQ: GNPX · Real-Time Price · USD
1.500
-0.080 (-5.06%)
Apr 2, 2026, 10:48 AM EDT - Market open
Genprex Market Cap
Genprex has a market cap or net worth of $3.48 million as of April 2, 2026. Its market cap has increased by 2.30% in one year.
Market Cap
3.48M
Enterprise Value
-4.17M
1-Year Change
2.30%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since March 29, 2018, Genprex's market cap has decreased from $11.30M to $3.48M, a decrease of -69.22%. That is a compound annual growth rate of -13.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 16.40M | 310.00% |
| Dec 31, 2025 | 4.00M | -44.44% |
| Dec 31, 2024 | 7.20M | -47.45% |
| Dec 29, 2023 | 13.70M | -80.32% |
| Dec 30, 2022 | 69.60M | 11.18% |
| Dec 31, 2021 | 62.60M | -61.92% |
| Dec 31, 2020 | 164.40M | 3,123.53% |
| Dec 31, 2019 | 5.10M | -69.28% |
| Dec 31, 2018 | 16.60M | 46.90% |
| Mar 29, 2018 | 11.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulmatrix | 4.71M |
| Revelation Biosciences | 4.46M |
| FibroBiologics | 4.46M |
| Moolec Science | 4.30M |
| Silexion Therapeutics | 4.26M |
| IO Biotech | 4.22M |
| Indaptus Therapeutics | 4.22M |
| Alzamend Neuro | 4.03M |